The observations suggest that the tumor suppressor gene CDKN2 is a potential candidate for ge ne replacement therapy of NSCLC.
结果表明肿瘤抑制基因CDKN2可望成为NSCLC基因替代治疗的候选基因。
The strategy targeted to the tumor suppressor gene that regulates the cell cycle directly, obtained satisfactory results, and provided a reliable theory for lung cancer gene therapy.
本项基因治疗策略以直接调控细胞周期的抑癌基因为靶向治疗基因，为肺癌基因治疗提供了可靠的理论依据。
应用推荐